1. A 3‐Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP‐6952 in Healthy Japanese Subjects and Those With ≤3 Spontaneous Bowel Movements per Week. Issue 3 (28th August 2019) Authors: Yumizaki, Takuya; Maeda, Mika; Fujita, Tomoe; Kakuyama, Hiroyoshi; Kumagai, Yuji Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 3(2020) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Double-Blind, Randomized, Crossover Comparative Study for Evaluating the Clinical Safety of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE). (5th August 2018) Authors: Odaguchi, Hiroshi; Sekine, Mariko; Hyuga, Sumiko; Hanawa, Toshihiko; Hoshi, Keika; Sasaki, Yoshinobu; Aso, Masako; Yang, Jinwei; Hyuga, Masashi; Kobayashi, Yoshinori; Hakamatsuka, Takashi; Goda, Yukihiro; Kumagai, Yuji Other Names: Namiki Takao Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Drug‐Drug Interaction Study to Evaluate the Effect of TAS‐303 on CYP3A Activity in the Small Intestine and Liver. (5th February 2020) Authors: Kumagai, Yuji; Fujita, Tomoe; Maeda, Mika; Sasaki, Yoshinobu; Nagaoka, Makoto; Huang, Jinhong; Takenaka, Toru; Kawai, Masaki Journal: Journal of clinical pharmacology Issue: Volume 60:Number 6(2020) Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling and Simulation. (13th July 2017) Authors: Saito, Tomohisa; Iida, Satofumi; Terao, Kimio; Kumagai, Yuji Journal: Journal of clinical pharmacology Issue: Volume 57:Number 12(2017) Page Start: 1564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial. (2nd August 2018) Authors: Kumagai, Yuji; Amano, Hideki; Sasaki, Yoshinobu; Nakagawa, Chie; Maeda, Mika; Oikawa, Ichiro; Furuie, Hidetoshi Journal: British journal of clinical pharmacology Issue: Volume 84:Number 10(2018) Page Start: 2393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects. Issue 3 (June 2015) Authors: Tomaru, Atsuko; Takeda-Morishita, Mariko; Maeda, Kazuya; Banba, Hirokazu; Takayama, Kozo; Kumagai, Yuji; Kusuhara, Hiroyuki; Sugiyama, Yuichi Journal: Drug metabolism and pharmacokinetics Issue: Volume 30:Issue 3(2015) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0156 A PHASE 1, SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF TAS5315—A NOVEL HIGHLY SELECTIVE INHIBITOR OF BRUTON'S TYROSINE KINASE—IN HEALTHY MALE VOLUNTEERS. (June 2019) Authors: Kumagai, Yuji; Tanaka, Yoshiya; Murata, Mitsuru; Takeuchi, Tsutomu Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study. Issue 5 (7th August 2017) Authors: Samukawa, Yoshishige; Sata, Michio; Furihata, Kenichi; Ito, Toshifumi; Ueda, Naohiko; Ochiai, Hidekazu; Sakai, Soichi; Kumagai, Yuji Journal: Clinical pharmacology in drug development Issue: Volume 6:Issue 5(2017) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κB. Issue 10 (9th August 2022) Authors: Kusumastuti, Ratih; Kumagai, Yuji; Ishihara, Seiichiro; Enomoto, Atsushi; Murakami, Takashi; Yasuda, Motoaki; Haga, Hisashi Journal: FEBS open bio Issue: Volume 12:Issue 10(2022) Page Start: 1797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Moxifloxacin‐induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study. (2nd July 2015) Authors: Morganroth, Joel; Wang, Yaning; Thorn, Michael; Kumagai, Yuji; Harris, Stuart; Stockbridge, Norman; Kleiman, Robert; Shah, Rashmi Journal: British journal of clinical pharmacology Issue: Volume 80:Number 3(2015:Sep.) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗